Cosmos Health (COSM) Director John Hoidas Receives 20,000-Share Award

What Happened

• Director John James Hoidas received a grant of 20,000 shares (RSUs) on May 19, 2026 that vested on the grant date and were converted into 20,000 shares of Cosmos Health common stock. The award is reported at $0.28 per share for a total value of approximately $5,660. The filing shows a related conversion of the derivative RSU into common stock.

Key Details

• Transaction date: May 19, 2026 (reported on Form 4 filed June 11, 2026).
• Reported amounts/prices: 20,000-share award at $0.28/share (total ≈ $5,660); conversion of 20,000 derivative shares reported at $0.00.
• Transaction codes: A = Award/Grant; C = Conversion of derivative security.
• Footnotes: Award granted under the Issuer’s 2024 & 2025 Omnibus Incentive Plan and exempt under Rule 16b-3; RSUs vested on grant date per filing.
• Shares owned after the transaction: not disclosed in the provided filing details.
• Timeliness: The Form 4 was filed on June 11, 2026 for a May 19, 2026 transaction, which is later than the typical two-business-day reporting window for Form 4s.

Context

• This was an award/vesting event (not a market purchase or sale). RSU grants that vest and convert into shares are a common compensation mechanism and do not by themselves indicate an insider buying or selling shares on the open market. The Rule 16b-3 exemption cited is standard for compensatory awards to insiders.